Results 1 to 10 of about 48,590 (264)
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
Toxins, 2017 Botulinum neurotoxins are diverse proteins. They are currently represented by at least seven serotypes and more than 40 subtypes. New clostridial strains that produce novel neurotoxin variants are being identified with increasing frequency, which ...
Luca Bano +2 more
exaly +3 more sources
Physical Treatments to Control Clostridium botulinum Hazards in Food
Foods, 2023 Clostridium botulinum produces Botulinum neurotoxins (BoNTs), causing a rare but potentially deadly type of food poisoning called foodborne botulism. This review aims to provide information on the bacterium, spores, toxins, and botulisms, and describe ...
Muhammad Tanveer Munir +6 more
doaj +1 more source
Treatment Results of Vocal Process Granuloma: Intubation versus Contact Granuloma
International Archives of Otorhinolaryngology, 2023 Introduction Contact granulomas (CGs) and intubation granulomas (IGs) are known to have different clinical manifestations despite having the same pathological features.
Joo Hyun Woo +3 more
doaj +1 more source
Toxins, 2023 In this randomized, double-blind, placebo-controlled study, we evaluated the efficacy of an individualized technique of subcutaneous injection of botulinum toxin type A (BoNT-A) targeted (SjBoT) to the occipital or trigeminal skin area in non-responder ...
Francesco Bono +9 more
doaj +1 more source
Clostridial Neurotoxins: Structure, Function and Implications to Other Bacterial Toxins
Microorganisms, 2021 Gram-positive bacteria are ancient organisms. Many bacteria, including Gram-positive bacteria, produce toxins to manipulate the host, leading to various diseases. While the targets of Gram-positive bacterial toxins are diverse, many of those toxins use a
Shuowei Cai, Raj Kumar, Bal Ram Singh
doaj +1 more source
Clinical and Epidemiological Aspects of Huntington Disease in the Republic of Tatarstan
Анналы клинической и экспериментальной неврологии, 2020 his study aimed to evaluate the epidemiological features ofHuntington disease (HD), based on data from the Centre for Extrapyramidal Pathology and Botulinum Toxin Therapy of theRepublic ofTatarstan. Materials and methods.
Sabina E. Munasipova +1 more
doaj +1 more source
Неврология, нейропсихиатрия, психосоматика, 2022 Amantadine has begun to be used as a possible alternative in COVID-19 therapy to mitigate its effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine and who test positive for COVID-19 often do not develop
Z. A. Zalyalova +5 more
doaj +1 more source
Cervical dystonia: non-motor aspects
Неврология, нейропсихиатрия, психосоматика, 2020 Cervical dystonia (CD) is manifested by violent, often painful movements of the neck muscles with the abnormal head and/or neck postures being formed. Disease progression leads to disability of patients.
O. A. Druzhinina +3 more
doaj +1 more source
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
Toxins, 2021 Botulinum neurotoxins (BoNTs) are potent inhibitors of synaptic vesicle fusion and transmitter release. The natural target of BoNTs is the peripheral neuromuscular junction (NMJ) where, by blocking the release of acetylcholine (ACh), they functionally ...
Siro Luvisetto
doaj +1 more source
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
Toxins, 2022 Botulinum toxin (BT) is an effective treatment for spasticity symptoms in multiple sclerosis (MS). Despite its wide use in clinical practices, only few studies have explored long-term persistence.
Federica Novarella +13 more
doaj +1 more source